BraubachOliver Bruker Spatial BiologyUnited States

Oliver Braubach joined Bruker as the Director of Research and Development in 2023. He is responsible for the ongoing development of the CellScape™ Precise Spatial Proteomics platform. The CellScape enables precise spatial multiplexing of proteins at any plex-level with cellular and subcellular resolution. Oliver’s R&D team is based in St. Louis, MO and Hannover, Germany. The team is committed to developing turnkey solutions for spatial multiplexing in discovery, translational and clinical research. Oliver has more than 15 years of experience in imaging and spatial biology, and he actively publishes research related to cancer immunology, neuroscience and infectious disease. Oliver received his PhD from Dalhousie University, Canada, and has developed multiple techniques aimed at democratizing and maximizing biomarker detection with optical microscopy.